Induced periosteum a complex cellular scaffold for the treatment of large bone defects

Bone

Volumn 57, Issue 2, 2013, Pages 484-492

  Cuthbert, Richard J ^a   Churchman, Sarah M ^a   Tan, Hiang B ^a,b   McGonagle, Dennis ^a   Jones, Elena ^a   Giannoudis, Peter V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Bone regeneration; Induced membrane; Induced periosteum; MSC; Osteoprogenitor cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE DEFECT; CELL ADHESION; CELL COMPOSITION; CELL EXPANSION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPHYSIS; ENDOTHELIUM CELL; FEMALE; FEMUR; HUMAN; HUMAN TISSUE; INDUCED PERIOSTEAL MEMBRANE; LYMPHOCYTE; MALE; MESENCHYMAL STROMA CELL; PERICYTE; PERIOSTEUM; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; TISSUE GRAFT;

BONE REGENERATION; INDUCED MEMBRANE; INDUCED-PERIOSTEUM; MSC; OSTEOPROGENITOR CELLS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE DISEASES; CELL DIFFERENTIATION; COLONY-FORMING UNITS ASSAY; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFLUIDICS; MIDDLE AGED; PERIOSTEUM; TISSUE SCAFFOLDS; YOUNG ADULT;

EID: 84886723955     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.08.009     Document Type: Article

References (46)

1. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
2. Reichert J.C., Saifzadeh S., Wullschleger M.E., Epari D.R., Schutz M.A., Duda G.N., et al. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 2009, 30:2149-2163.
3. Talbot M., Zdero R., Garneau D., Cole P.A., Schemitsch E.H. Fixation of long bone segmental defects: a biomechanical study. Injury 2008, 39:181-186.
4. Keating J.F., Simpson A.H., Robinson C.M. The management of fractures with bone loss. J Bone Joint Surg Br 2005, 87:142-150.
5. Gugala Z., Gogolewski S. Regeneration of segmental diaphyseal defects in sheep tibiae using resorbable polymeric membranes: a preliminary study. J Orthop Trauma 1999, 13:187-195.
6. Warnke P.H., Springer I.N., Wiltfang J., Acil Y., Eufinger H., Wehmoller M., et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004, 364:766-770.
7. Masquelet A.C. Muscle reconstruction in reconstructive surgery: soft tissue repair and long bone reconstruction. Langenbecks Arch Surg 2003, 388:344-346.
8. Retzepi M., Donos N. Guided bone regeneration: biological principle and therapeutic applications. Clin Oral Implants Res 2010, 21:567-576.
9. Giannoudis P.V., Faour O., Goff T., Kanakaris N., Dimitriou R. Masquelet technique for the treatment of bone defects: tips-tricks and future directions. Injury 2011, 42:591-598.
10. Masquelet A.C., Begue T. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am 2010, 41:27-37.
11. Pelissier P., Masquelet A.C., Bareille R., Pelissier S.M., Amedee J. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 2004, 22:73-79.
12. Arnsdorf E.J., Jones L.M., Carter D.R., Jacobs C.R. The periosteum as a cellular source for functional tissue engineering. Tissue Eng Part A 2009, 15:2637-2642.
13. Chan H., Knothe Tate M.L. Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells. Stem Cells Transl Med 2012, 480-491.
14. Young R.W. Cell proliferation and specialization during endochondral osteogenesis in young rats. J Cell Biol 1962, 14:357-370.
15. Fan W., Crawford R., Xiao Y. Structural and cellular differences between metaphyseal and diaphyseal periosteum in different aged rats. Bone 2008, 42:81-89.
16. Squier C.A., Ghoneim S., Kremenak C.R. Ultrastructure of the periosteum from membrane bone. J Anat 1990, 171:233-239.
17. Ng A.M., Saim A.B., Tan K.K., Tan G.H., Mokhtar S.A., Rose I.M., et al. Comparison of bioengineered human bone construct from four sources of osteogenic cells. J Orthop Sci 2005, 10:192-199.
18. De Bari C., Dell'Accio F., Vanlauwe J., Eyckmans J., Khan I., Archer C.W., et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006, 54:1209-2121.
19. De Bari C., Dell'Accio F., Karystinou A., Guillot P.V., Fisk N.M., Jones E.A., et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 2008, 58:240-250.
20. Knothe U.R., Springfield D.S. A novel surgical procedure for bridging of massive bone defects. World J Surg Oncol 2005, 3:7.
21. Yu Y.Y., Lieu S., Lu C., Colnot C. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 2010, 47:65-73.
22. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
23. Chen C.W., Montelatici E., Crisan M., Corselli M., Huard J., Lazzari L., et al. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both?. Cytokine Growth Factor Rev 2009, 20:429-434.
24. Stratman A.N., Davis G.E. Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal 2012, 18:68-80.
25. Jones E., English A., Churchman S.M., Kouroupis D., Boxall S.A., Kinsey S., et al. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum 2010, 62:1944-1954.
26. Jones E.A., English A., Kinsey S.E., Emery P., McGonagle D.G., Jones R.A., et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002, 46:3349-3360.
27. Cuthbert R., Boxall S.A., Tan H.B., Giannoudis P.V., McGonagle D., Jones E. Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. Cytotherapy 2012, 14:431-440.
28. Jones E., Ponchel F., Field S.L., Martin S.G., Emery P., McGonagle D. The value of cell surface and molecular markers to define multipotential mesenchymal stem cells from bone marrow and synovial fluid. Arthritis Rheum 2004, 50:S56-S56.
29. Jones E.A., Crawford A., English A., Henshaw K., Mundy J., Corscadden D., et al. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum 2008, 58:1731-1740.
30. Jones E.A., English A., Henshaw K., Kinsey S.E., Markham A.F., Emery P., et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004, 50:817-827.
31. Jones E.A., English A., Kinsey S.E., Straszynski L., Emery P., Ponchel F., et al. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom 2006, 70:391-399.
32. Jones E., Churchman S.M., English A., Buch M.H., Horner E.A., Burgoyne C.H., et al. Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level. Ann Rheum Dis 2010, 69:450-457.
33. Quirici N., Soligo D., Bossolasco P., Servida F., Lumini C., Deliliers G.L. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002, 30:783-791.
34. Churchman S.M., Ponchel F., Boxall S.A., Cuthbert R., Kouroupis D., Roshdy T., et al. Transcriptional profile of native CD271+ multipotential stromal cells: Evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity. Arthritis Rheum 2012, 64:2632-2643.
35. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
36. Smith M.D., Baeten D., Ulfgren A.K., McInnes I.B., Fitzgerald O., Bresnihan B., et al. Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?. Ann Rheum Dis 2006, 65:93-100.
37. Gruber H.E., Riley F.E., Hoelscher G.L., Bayoumi E.M., Ingram J.A., Ramp W.K., et al. Osteogenic and chondrogenic potential of biomembrane cells from the PMMA-segmental defect rat model. J Orthop Res 2012, 30:1198-1212.
38. Friedenstein A.J., Latzinik N.V., Gorskaya Y.F., Luria E.A., Moskvina I.L. Bone-marrow stromal colony formation requires stimulation by hematopoietic-cells. Bone Miner 1992, 18:199-213.
39. Banfi A., Bianchi G., Notaro R., Luzzatto L., Cancedda R., Quarto R. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng 2002, 8:901-910.
40. Francois M., Copland I.B., Yuan S., Romieu-Mourez R., Waller E.K., Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing. Cytotherapy 2012, 14:147-152.
41. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
42. Maksym R.B., Tarnowski M., Grymula K., Tarnowska J., Wysoczynski M., Liu R., et al. The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur J Pharmacol 2009, 625:31-40.
43. Miller R.J., Banisadr G., Bhattacharyya B.J. CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 2008, 198:31-38.
44. Covas D.T., Panepucci R.A., Fontes A.M., Silva W.A., Orellana M.D., Freitas M.C.C., et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146(+) perivascular cells and fibroblasts. Exp Hematol 2008, 36:642-654.
45. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
46. Gretzer C., Emanuelsson L., Liljensten E., Thomsen P. The inflammatory cell influx and cytokines changes during transition from acute inflammation to fibrous repair around implanted materials. J Biomater Sci Polym Ed 2006, 17:669-687.